Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy.
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D000328:Adult; D001706:Biopsy; D004054:Diethylstilbestrol / Q000009:adverse effects* / Q000627:therapeutic use; D004717:Endometrium; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D007044:Hysterectomy; D007621:Karyotyping; D008525:Medroxyprogesterone / Q000627:therapeutic use; D014424:Turner Syndrome / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000601:surgery
D006908:Hydroxyprogesterones; D004054:Diethylstilbestrol; D008525:Medroxyprogesterone